Medipharm Labs Corp T.LABS

Alternate Symbol(s): MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.

TSX:LABS - Post by User

Medipharm Labs Corp

<< Previous

Bullboard Posts

Next >>

Post by lscfaon Apr 13, 2022 6:43pm

188 Views

Post# 34602138

Valens vs Medipharm

The bozos at Valens can't make money with revenues $30 million per qtr. Medipharm would be profitable at that level. Corp. costs not as bloated as Valens.

	Revenue	Revenue	Adj. ebitda	Adj. ebitda
	MediPharm	Valens	MediPharm	Valens
Q1 22		29,867		(17,646)
Q4 21	5,743	23,342	(6,573)	(13,347)
Q3 21	5,401	24,569	(5,622)	(6,183)
Q2 21	5,072	20,469	(3,675)	(4,960)
Q1 21	5,495	21,774	(6,159)	(2,241)
Q4 20	6,058	16,044	(8,767)	(4,280)
Q3 20	4,947	18,128	(7,262)	1,440
Q2 20	13,918	17,627	(2,180)	2,699
Q1 20	11,089	31,980	(5,657)	14,282
Q4 19	32,444	30,624	2,661	17,669
Q3 19	43,386	16,462	10,066	9,772
Q2 19	31,472	8,800	7,700	2,023
Q1 19	21,950	2,220	4,310	(2,029)